A5078309261- Advanced Breast Cancer Therapies
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
- Breast Cancer Treatment Studies
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Birth, Development, and Health
- Estrogen and related hormone effects
- Brain Metastases and Treatment
- Dementia and Cognitive Impairment Research
- Bioinformatics and Genomic Networks
- Psychological Well-being and Life Satisfaction
- Gene expression and cancer classification
- Immunotherapy and Immune Responses
- Cancer Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Lung Cancer Diagnosis and Treatment
- Cancer Risks and Factors
- Cardiac Health and Mental Health
- Cancer therapeutics and mechanisms
- Neutropenia and Cancer Infections
- Cancer survivorship and care
- PI3K/AKT/mTOR signaling in cancer
- Immune Cell Function and Interaction
Wenzhou Medical University
2024-2025
First Affiliated Hospital of Wenzhou Medical University
2024-2025
Peking University
2019-2023
Peking University Cancer Hospital
2019-2023
Sichuan Cancer Hospital
2020
To identify latent classes of cognitive impairment and co-occurring symptoms (fatigue, pain, sleep disturbance, depression) as clusters in patients with prostate cancer undergoing androgen deprivation therapy to explore the predictors among distinct classes. A total 228 were recruited this cross-sectional study. The assessment instrument included Perceived Cognitive Impairment Scale, Fatigue Severity Athens Insomnia Brief Pain Inventory, Patient Health Questionnaire-9, UCLA Loneliness...
Abemaciclib (oral CDK4 and 6 inhibitor) plus endocrine therapy (ET) as adjuvant treatment demonstrated clinically meaningful improvement in invasive disease-free survival (IDFS) distant relapse-free (DRFS) Chinese patients (pts) with Hormone Receptor (HR+)-positive human epidermal growth factor 2 (HER2)-negative high risk early breast cancer (EBC). This combination provided sustained clinical benefits at the pre-planned overall interim analysis (OS IA2). Here we present results of subset...